Korea Research Institute of Bioscience and
Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to
biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated
biotechnology and bio information. KRIBB was established in 1985. Its accomplishments include the advancement of welfare and medical technology, an increase in food production, a cleaner environment and new bio-materials and energy sources.
It has identified reasons for the failure of animal cloning, conducted a comparative study of chimpanzee genes and successfully analysed the structure of the
reactive oxygen species switch protein, which became the first study by Korean scholars to be published in Cell, an international scientific journal. The institute was ranked first in the discovery of new microorganisms, including the indigenous
microorganisms of the Dokdo Islets, for four consecutive years. Its recent accomplishments include the development of a
genome capable of controlling
cancer cell proliferation and the identification of a neuropeptide Y-based growth control mechanism, with possibilities for new treatments for cancer, diabetes,
obesity and ageing. Nano–bio sensor research led to the development of the worlds smallest surface plasmon resonance biochip.
• Carry out R&D activities and related projects in bioscience and
biotechnology with other research institutes, academic and
business at home and abroad.
• Disseminate the results of its scientific research and technological development
Statistics:
• Headquarters (Human Gene Bank, Plant Extract Bank, KCTC): 100,978 square metres (1,086,920 sq ft)
• Bio-Therapeutic Research Institute (Ochang Campus): 212,258 square metres (2,284,730 sq ft)
• Bio-Materials Research Institute (Jeonbuk Campus): 43,559 square metres (468,870 sq ft).
Last Updated on: Nov 25, 2024